BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Braun A, Treede I, Gotthardt D, Tietje A, Zahn A, Ruhwald R, Schoenfeld U, Welsch T, Kienle P, Erben G, Lehmann W, Fuellekrug J, Stremmel W, Ehehalt R. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis: . Inflammatory Bowel Diseases 2009;15:1705-20. [DOI: 10.1002/ibd.20993] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Kennelly JP, Carlin S, Ju T, van der Veen JN, Nelson RC, Buteau J, Thiesen A, Richard C, Willing BP, Jacobs RL. Intestinal Phospholipid Disequilibrium Initiates an ER Stress Response That Drives Goblet Cell Necroptosis and Spontaneous Colitis in Mice. Cell Mol Gastroenterol Hepatol 2021;11:999-1021. [PMID: 33238221 DOI: 10.1016/j.jcmgh.2020.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ohnishi T, Hashizume C, Taniguchi M, Furumoto H, Han J, Gao R, Kinami S, Kosaka T, Okazaki T. Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer. FASEB J 2017;31:3816-30. [PMID: 28522594 DOI: 10.1096/fj.201601225RR] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 4.6] [Reference Citation Analysis]
3 Zhang Y, Thanou M, Vllasaliu D. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. Eur J Pharm Biopharm 2020;155:128-38. [PMID: 32853696 DOI: 10.1016/j.ejpb.2020.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mirsepasi-Lauridsen HC, Halkjaer SI, Mortensen EM, Lydolph MC, Nordgaard-Lassen I, Krogfelt KA, Petersen AM. Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis. Sci Rep 2016;6:31152. [PMID: 27686530 DOI: 10.1038/srep31152] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
5 Rusconi B, Jiang X, Sidhu R, Ory DS, Warner BB, Tarr PI. Gut Sphingolipid Composition as a Prelude to Necrotizing Enterocolitis. Sci Rep 2018;8:10984. [PMID: 30030452 DOI: 10.1038/s41598-018-28862-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ben-Ami Shor D, Bashi T, Lachnish J, Fridkin M, Bizzaro G, Barshak I, Blank M, Shoenfeld Y. Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease. J Autoimmun 2015;56:111-7. [PMID: 25479760 DOI: 10.1016/j.jaut.2014.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
7 Frasch SC, McNamee EN, Kominsky D, Jedlicka P, Jakubzick C, Zemski Berry K, Mack M, Furuta GT, Lee JJ, Henson PM, Colgan SP, Bratton DL. G2A Signaling Dampens Colitic Inflammation via Production of IFN-γ. J Immunol 2016;197:1425-34. [PMID: 27402702 DOI: 10.4049/jimmunol.1600264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
8 Arshad U, Zenobi MG, Staples CR, Santos JEP. Meta-analysis of the effects of supplemental rumen-protected choline during the transition period on performance and health of parous dairy cows. J Dairy Sci 2020;103:282-300. [PMID: 31677842 DOI: 10.3168/jds.2019-16842] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
9 Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. [PMID: 26582965 DOI: 10.1155/2015/628157] [Cited by in Crossref: 221] [Cited by in F6Publishing: 212] [Article Influence: 31.6] [Reference Citation Analysis]
10 Braun A, Schönfeld U, Welsch T, Kadmon M, Funke B, Gotthardt D, Zahn A, Autschbach F, Kienle P, Zharnikov M, Grunze M, Stremmel W, Ehehalt R. Reduced hydrophobicity of the colonic mucosal surface in ulcerative colitis as a hint at a physicochemical barrier defect. Int J Colorectal Dis 2011;26:989-98. [PMID: 21455745 DOI: 10.1007/s00384-011-1190-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
11 Miklavcic JJ, Hart TD, Lees GM, Shoemaker GK, Schnabl KL, Larsen BM, Bathe OF, Thomson AB, Mazurak VC, Clandinin MT. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease. World J Gastroenterol 2015; 21(35): 10080-10090 [PMID: 26401073 DOI: 10.3748/wjg.v21.i35.10080] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
12 Catalan-Serra I, Brenna Ø. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Hum Vaccin Immunother 2018;14:2597-611. [PMID: 29624476 DOI: 10.1080/21645515.2018.1461297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
13 Slone EA, Fleming SD. Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury. Clin Immunol. 2014;153:228-240. [PMID: 24814240 DOI: 10.1016/j.clim.2014.04.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
14 Abdel Hadi L, Di Vito C, Riboni L. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces. Mediators Inflamm 2016;2016:3827684. [PMID: 26880864 DOI: 10.1155/2016/3827684] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
15 Sparkes BL, Slone EE, Roth M, Welti R, Fleming SD. Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochim Biophys Acta. 2010;1801:517-525. [PMID: 20083230 DOI: 10.1016/j.bbalip.2010.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
16 Ding H, Dupont AW, Singhal S, Scott LD, Guha S, Younes M, Bi X. In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy. Biomed Opt Express 2017;8:3426-39. [PMID: 28717578 DOI: 10.1364/BOE.8.003426] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
17 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Csáki KF. Synthetic surfactant food additives can cause intestinal barrier dysfunction. Medical Hypotheses 2011;76:676-81. [DOI: 10.1016/j.mehy.2011.01.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
19 Espaillat MP, Kew RR, Obeid LM. Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis. Adv Biol Regul 2017;63:140-55. [PMID: 27866974 DOI: 10.1016/j.jbior.2016.11.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
20 Qi Y, Jiang C, Tanaka N, Krausz KW, Brocker CN, Fang ZZ, Bredell BX, Shah YM, Gonzalez FJ. PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate. Am J Physiol Gastrointest Liver Physiol 2014;307:G564-73. [PMID: 25035112 DOI: 10.1152/ajpgi.00153.2014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
21 Lee EG, Yoon YC, Yoon J, Lee SJ, Oh YK, Kwon SW. Systematic Review of Recent Lipidomics Approaches Toward Inflammatory Bowel Disease. Biomol Ther (Seoul) 2021;29:582-95. [PMID: 34565718 DOI: 10.4062/biomolther.2021.125] [Reference Citation Analysis]
22 Effinger A, M O'Driscoll C, McAllister M, Fotaki N. Gastrointestinal diseases and their impact on drug solubility: Ulcerative Colitis. Eur J Pharm Sci 2020;152:105458. [PMID: 32645424 DOI: 10.1016/j.ejps.2020.105458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Gotthardt D, Braun A, Tietje A, Weiss KH, Ehehalt R, Stremmel WR. Separate basolateral and apical phosphatidylcholine secretion routes in intestinally differentiated tumor cells. World J Gastroenterol 2009; 15(46): 5821-5826 [PMID: 19998503 DOI: 10.3748/wjg.15.5821] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 2012;64:557-70. [PMID: 22212900 DOI: 10.1016/j.addr.2011.12.009] [Cited by in Crossref: 931] [Cited by in F6Publishing: 826] [Article Influence: 93.1] [Reference Citation Analysis]
25 Marques JG, Shokry E, Frivolt K, Werkstetter KJ, Brückner A, Schwerd T, Koletzko S, Koletzko B. Metabolomic Signatures in Pediatric Crohn's Disease Patients with Mild or Quiescent Disease Treated with Partial Enteral Nutrition: A Feasibility Study. SLAS Technol 2021;26:165-77. [PMID: 33207993 DOI: 10.1177/2472630320969147] [Reference Citation Analysis]
26 Orel R, Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol 2014; 20(33): 11505-11524 [PMID: 25206258 DOI: 10.3748/wjg.v20.i33.11505] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 88] [Article Influence: 13.3] [Reference Citation Analysis]
27 Hunter AC, Elsom J, Wibroe PP, Moghimi SM. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Nanomedicine 2012;8 Suppl 1:S5-20. [PMID: 22846372 DOI: 10.1016/j.nano.2012.07.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
28 Rogler G, Vavricka S, Schoepfer A, Lakatos PL. Mucosal healing and deep remission: What does it mean? World J Gastroenterol 2013; 19(43): 7552-7560 [PMID: 24282345 DOI: 10.3748/wjg.v19.i43.7552] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
29 Parian AM, Mullin GE, Langhorst J, Brown AC. Inflammatory Bowel Disease. Integrative Medicine. Elsevier; 2018. pp. 501-516.e8. [DOI: 10.1016/b978-0-323-35868-2.00050-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Sewell GW, Hannun YA, Han X, Koster G, Bielawski J, Goss V, Smith PJ, Rahman FZ, Vega R, Bloom SL, Walker AP, Postle AD, Segal AW. Lipidomic profiling in Crohn's disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition. Int J Biochem Cell Biol 2012;44:1839-46. [PMID: 22728312 DOI: 10.1016/j.biocel.2012.06.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
31 Wang YJ, Li QM, Zha XQ, Luo JP. Intervention and potential mechanism of non-starch polysaccharides from natural resources on ulcerative colitis: A review. Int J Biol Macromol 2022;210:545-64. [PMID: 35513106 DOI: 10.1016/j.ijbiomac.2022.04.208] [Reference Citation Analysis]
32 Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1165-1179 [PMID: 24574793 DOI: 10.3748/wjg.v20.i5.1165] [Cited by in CrossRef: 169] [Cited by in F6Publishing: 149] [Article Influence: 21.1] [Reference Citation Analysis]
33 Stremmel W, Staffer S, Stuhrmann N, Gan-Schreier H, Gauss A, Burger N, Hornuss D. Phospholipase A2 of Microbiota as Pathogenetic Determinant to Induce Inflammatory States in Ulcerative Colitis: Therapeutic Implications of Phospholipase A2 Inhibitors. Inflamm Intest Dis 2018;2:180-7. [PMID: 29922677 DOI: 10.1159/000486858] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
34 Li Q, Chen G, Zhu D, Zhang W, Qi S, Xue X, Wang K, Wu L. Effects of dietary phosphatidylcholine and sphingomyelin on DSS-induced colitis by regulating metabolism and gut microbiota in mice. J Nutr Biochem 2022;:109004. [PMID: 35351615 DOI: 10.1016/j.jnutbio.2022.109004] [Reference Citation Analysis]
35 Daniluk U, Daniluk J, Kucharski R, Kowalczyk T, Pietrowska K, Samczuk P, Filimoniuk A, Kretowski A, Lebensztejn D, Ciborowski M. Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study. Inflamm Bowel Dis 2019;25:1120-8. [PMID: 30772902 DOI: 10.1093/ibd/izy402] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
36 Otake-kasamoto Y, Kayama H, Kishikawa T, Shinzaki S, Tashiro T, Amano T, Tani M, Yoshihara T, Li B, Tani H, Liu L, Hayashi A, Okuzaki D, Motooka D, Nakamura S, Okada Y, Iijima H, Takeda K, Takehara T. Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response. Journal of Experimental Medicine 2022;219:e20211291. [DOI: 10.1084/jem.20211291] [Reference Citation Analysis]
37 Cheng F, Zhang Y, Li Q, Zeng F, Wang K. Inhibition of Dextran Sodium Sulfate-Induced Experimental Colitis in Mice by Angelica Sinensis Polysaccharide. J Med Food 2020;23:584-92. [PMID: 32282259 DOI: 10.1089/jmf.2019.4607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Cai H, Wen Z, Meng K, Yang P. Metabolomic signatures for liver tissue and cecum contents in high-fat diet-induced obese mice based on UHPLC-Q-TOF/MS. Nutr Metab (Lond) 2021;18:69. [PMID: 34193189 DOI: 10.1186/s12986-021-00595-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Ding H, Dupont AW, Singhal S, Scott LD, Guha S, Younes M, Ye Y, Bi X. Effect of physiological factors on the biochemical properties of colon tissue - an in vivo Raman spectroscopy study: Physiological factors on the biochemical properties of colon tissue. J Raman Spectrosc 2017;48:902-9. [DOI: 10.1002/jrs.5140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
40 Titz B, Gadaleta RM, Lo Sasso G, Elamin A, Ekroos K, Ivanov NV, Peitsch MC, Hoeng J. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.Int J Mol Sci. 2018;19. [PMID: 30223557 DOI: 10.3390/ijms19092775] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
41 Quinville BM, Deschenes NM, Ryckman AE, Walia JS. A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis. Int J Mol Sci 2021;22:5793. [PMID: 34071409 DOI: 10.3390/ijms22115793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Olson A, Diebel LN, Liberati DM. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin. J Trauma Acute Care Surg 2014;77:570-5; discussion 576. [PMID: 25250596 DOI: 10.1097/TA.0000000000000378] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
43 Raad MA, Chams NH, Sharara AI. New and Evolving Immunotherapy in Inflammatory Bowel Disease. Inflamm Intest Dis. 2016;1:85-95. [PMID: 29922662 DOI: 10.1159/000445986] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
44 Vetter M, Neurath MF. Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challenges. Therap Adv Gastroenterol 2017;10:773-90. [PMID: 29051788 DOI: 10.1177/1756283X17727388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
45 Stremmel W, Staffer S, Schneider MJ, Gan-Schreier H, Wannhoff A, Stuhrmann N, Gauss A, Wolburg H, Mahringer A, Swidsinski A, Efferth T. Genetic Mouse Models with Intestinal-Specific Tight Junction Deletion Resemble an Ulcerative Colitis Phenotype. J Crohns Colitis 2017;11:1247-57. [PMID: 28575164 DOI: 10.1093/ecco-jcc/jjx075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
46 Amadei F, Fröhlich B, Stremmel W, Tanaka M. Nonclassical Interactions of Phosphatidylcholine with Mucin Protect Intestinal Surfaces: A Microinterferometry Study. Langmuir 2018;34:14046-57. [PMID: 30359036 DOI: 10.1021/acs.langmuir.8b03035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
47 Stremmel W, Lukasova M, Weiskirchen R. The neglected biliary mucus and its phosphatidylcholine content: a putative player in pathogenesis of primary cholangitis-a narrative review article. Ann Transl Med 2021;9:738. [PMID: 33987436 DOI: 10.21037/atm-20-3591] [Reference Citation Analysis]
48 Bauset C, Gisbert-Ferrándiz L, Cosín-Roger J. Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease. J Clin Med 2021;10:622. [PMID: 33562024 DOI: 10.3390/jcm10040622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
49 Zhang S, Cao X, Huang H. Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research. Front Cell Infect Microbiol 2017;7:51. [PMID: 28286741 DOI: 10.3389/fcimb.2017.00051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
50 Knights D, Parfrey LW, Zaneveld J, Lozupone C, Knight R. Human-associated microbial signatures: examining their predictive value. Cell Host Microbe 2011;10:292-6. [PMID: 22018228 DOI: 10.1016/j.chom.2011.09.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 75] [Article Influence: 9.1] [Reference Citation Analysis]
51 Mirsepasi-Lauridsen HC, Vallance BA, Krogfelt KA, Petersen AM. Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease. Clin Microbiol Rev. 2019;32. [PMID: 30700431 DOI: 10.1128/cmr.00060-18] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 16.7] [Reference Citation Analysis]
52 Liu MM, Coleman S, Wilkinson L, Smith ML, Hoang T, Niyah N, Mukherjee M, Huynh S, Parker CT, Kovac J, Hancock REW, Gaynor EC. Unique inducible filamentous motility identified in pathogenic Bacillus cereus group species. ISME J 2020;14:2997-3010. [PMID: 32770116 DOI: 10.1038/s41396-020-0728-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Coats SR, Hashim A, Paramonov NA, To TT, Curtis MA, Darveau RP. Cardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine. Appl Environ Microbiol 2016;82:4264-78. [PMID: 27208127 DOI: 10.1128/AEM.00463-16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Stremmel W, Staffer S, Gan-Schreier H, Wannhoff A, Bach M, Gauss A. Phosphatidylcholine passes through lateral tight junctions for paracellular transport to the apical side of the polarized intestinal tumor cell-line CaCo2. Biochim Biophys Acta 2016;1861:1161-9. [PMID: 27365309 DOI: 10.1016/j.bbalip.2016.06.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
55 Gauss A, Ehehalt R, Lehmann WD, Erben G, Weiss KH, Schaefer Y, Kloeters-Plachky P, Stiehl A, Stremmel W, Sauer P, Gotthardt DN. Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis. World J Gastroenterol 2013; 19(33): 5454-5463 [PMID: 24023488 DOI: 10.3748/wjg.v19.i33.5454] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
56 Schneider H, Braun A, Füllekrug J, Stremmel W, Ehehalt R. Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation. Int J Mol Sci 2010;11:4149-64. [PMID: 21152327 DOI: 10.3390/ijms11104149] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
57 Ramachandran R, Hyun E, Zhao L, Lapointe TK, Chapman K, Hirota CL, Ghosh S, McKemy DD, Vergnolle N, Beck PL, Altier C, Hollenberg MD. TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci U S A 2013;110:7476-81. [PMID: 23596210 DOI: 10.1073/pnas.1217431110] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 10.4] [Reference Citation Analysis]
58 Kovács T, Varga G, Erces D, Tőkés T, Tiszlavicz L, Ghyczy M, Vécsei L, Boros M, Kaszaki J. [Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease]. Magy Seb 2012;65:191-7. [PMID: 22940387 DOI: 10.1556/MaSeb.65.2012.4.4] [Reference Citation Analysis]
59 Cetinkaya M, Cansev M, Cekmez F, Tayman C, Canpolat FE, Kafa IM, Uysal S, Tunc T, Sarici SU. CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis. J Surg Res 2013;183:119-28. [PMID: 23228325 DOI: 10.1016/j.jss.2012.11.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
60 Davies JM, Hua HU, Dheer R, Martinez M, Bhattacharya SK, Abreu MT. Stool phospholipid signature is altered by diet and tumors. PLoS One 2014;9:e114352. [PMID: 25469718 DOI: 10.1371/journal.pone.0114352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
61 Torres J, Danese S, Colombel JF. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut 2013;62:1642-52. [PMID: 24104885 DOI: 10.1136/gutjnl-2012-303959] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
62 Ciardo MG, Ferrer-Montiel A. Lipids as central modulators of sensory TRP channels. Biochim Biophys Acta Biomembr 2017;1859:1615-28. [PMID: 28432033 DOI: 10.1016/j.bbamem.2017.04.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
63 Rogler G. Resolution of inflammation in inflammatory bowel disease. Lancet Gastroenterol Hepatol 2017;2:521-30. [PMID: 28606878 DOI: 10.1016/S2468-1253(17)30031-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
64 Brinchmann MF. Immune relevant molecules identified in the skin mucus of fish using -omics technologies. Mol Biosyst 2016;12:2056-63. [PMID: 27173837 DOI: 10.1039/c5mb00890e] [Cited by in Crossref: 67] [Cited by in F6Publishing: 19] [Article Influence: 13.4] [Reference Citation Analysis]
65 De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 2015;64:447-58. [PMID: 24811995 DOI: 10.1136/gutjnl-2013-306423] [Cited by in Crossref: 123] [Cited by in F6Publishing: 115] [Article Influence: 17.6] [Reference Citation Analysis]
66 Yamazaki T, Kadokura M, Mutoh Y, Sakamoto T, Okazaki M, Mitsumoto A, Kawashima Y, Kudo N. Inducing effect of clofibric acid on stearoyl-CoA desaturase in intestinal mucosa of rats. Lipids 2014;49:1203-14. [PMID: 25362535 DOI: 10.1007/s11745-014-3965-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
67 Leucht K, Fischbeck A, Caj M, Liebisch G, Hartlieb E, Benes P, Fried M, Humpf HU, Rogler G, Hausmann M. Sphingomyelin and phosphatidylcholine contrarily affect the induction of apoptosis in intestinal epithelial cells. Mol Nutr Food Res 2014;58:782-98. [PMID: 24142587 DOI: 10.1002/mnfr.201300369] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
68 Heischmann S, Dzieciatkowska M, Hansen K, Leibfritz D, Christians U. The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model. Sci Rep 2017;7:45088. [PMID: 28327659 DOI: 10.1038/srep45088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
69 van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017;1859:1558-1572. [PMID: 28411170 DOI: 10.1016/j.bbamem.2017.04.006] [Cited by in Crossref: 298] [Cited by in F6Publishing: 280] [Article Influence: 59.6] [Reference Citation Analysis]
70 Gong H, Yuan Q, Pang J, Li T, Li J, Zhan B, Chang R, Mao X. Dietary Milk Fat Globule Membrane Restores Decreased Intestinal Mucosal Barrier Development and Alterations of Intestinal Flora in Infant-Formula-Fed Rat Pups. Mol Nutr Food Res 2020;64:e2000232. [PMID: 32918844 DOI: 10.1002/mnfr.202000232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Berger E, Colosetti P, Jalabert A, Meugnier E, Wiklander OPB, Jouhet J, Errazurig-Cerda E, Chanon S, Gupta D, Rautureau GJP, Geloen A, El-Andaloussi S, Panthu B, Rieusset J, Rome S. Use of Nanovesicles from Orange Juice to Reverse Diet-Induced Gut Modifications in Diet-Induced Obese Mice. Mol Ther Methods Clin Dev 2020;18:880-92. [PMID: 32953937 DOI: 10.1016/j.omtm.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
72 Antoni L, Nuding S, Weller D, Gersemann M, Ott G, Wehkamp J, Stange EF. Human colonic mucus is a reservoir for antimicrobial peptides. J Crohns Colitis. 2013;7:e652-e664. [PMID: 23787054 DOI: 10.1016/j.crohns.2013.05.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
73 Chittim CL, Martínez del Campo A, Balskus EP. Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline. Nat Microbiol 2019;4:155-63. [DOI: 10.1038/s41564-018-0294-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
74 Hunter AC, Elsom J, Wibroe PP, Moghimi SM. Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective. Maturitas 2012;73:5-18. [DOI: 10.1016/j.maturitas.2012.05.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
75 Giles DK, Hankins JV, Guan Z, Trent MS. Remodelling of the Vibrio cholerae membrane by incorporation of exogenous fatty acids from host and aquatic environments. Mol Microbiol 2011;79:716-28. [PMID: 21255114 DOI: 10.1111/j.1365-2958.2010.07476.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
76 Effinger A, O'driscoll CM, Mcallister M, Fotaki N. Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review. Journal of Pharmacy and Pharmacology 2019;71:674-98. [DOI: 10.1111/jphp.12928] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
77 Korytowski A, Abuillan W, Amadei F, Makky A, Gumiero A, Sinning I, Gauss A, Stremmel W, Tanaka M. Accumulation of phosphatidylcholine on gut mucosal surface is not dominated by electrostatic interactions. Biochim Biophys Acta Biomembr 2017;1859:959-65. [PMID: 28212861 DOI: 10.1016/j.bbamem.2017.02.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
78 Kalenyak K, Heilmann RM, van de Lest CHA, Brouwers JF, Burgener IA. Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment. PLoS One 2019;14:e0215435. [PMID: 30990833 DOI: 10.1371/journal.pone.0215435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
79 Bollatti JM, Zenobi MG, Artusso NA, Alfaro GF, Lopez AM, Barton BA, Nelson CD, Staples CR, Santos JEP. Timing of initiation and duration of feeding rumen-protected choline affects performance of lactating Holstein cows. J Dairy Sci 2020;103:4174-91. [PMID: 32171515 DOI: 10.3168/jds.2019-17293] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
80 Carlson TL, Lock JY, Carrier RL. Engineering the Mucus Barrier. Annu Rev Biomed Eng 2018;20:197-220. [PMID: 29865871 DOI: 10.1146/annurev-bioeng-062117-121156] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
81 Zenobi M, Scheffler T, Zuniga J, Poindexter M, Campagna S, Castro Gonzalez H, Farmer A, Barton B, Santos J, Staples C. Feeding increasing amounts of ruminally protected choline decreased fatty liver in nonlactating, pregnant Holstein cows in negative energy status. Journal of Dairy Science 2018;101:5902-23. [DOI: 10.3168/jds.2017-13973] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
82 Stolfi C, Maresca C, Monteleone G, Laudisi F. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines 2022;10:289. [DOI: 10.3390/biomedicines10020289] [Reference Citation Analysis]
83 Herrlinger K, Wittig B, Stange EF. [Chronic inflammatory intestinal diseases. Pathophysiology and therapy]. Internist (Berl) 2009;50:1229-46; quiz 1247. [PMID: 19777197 DOI: 10.1007/s00108-009-2485-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Hughes KR, Schofield Z, Dalby MJ, Caim S, Chalklen L, Bernuzzi F, Alcon-Giner C, Le Gall G, Watson AJM, Hall LJ. The early life microbiota protects neonatal mice from pathological small intestinal epithelial cell shedding. FASEB J 2020;34:7075-88. [PMID: 32253791 DOI: 10.1096/fj.202000042R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
85 Stremmel W, Ehehalt R, Staffer S, Stoffels S, Mohr A, Karner M, Braun A. Mucosal protection by phosphatidylcholine. Dig Dis. 2012;30 Suppl 3:85-91. [PMID: 23295697 DOI: 10.1159/000342729] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
86 He Y, Liu Y, Ji P. Metabolomic Profile of Weaned Pigs Challenged with E. coli and Supplemented with Carbadox or Bacillus subtilis. Metabolites 2021;11:81. [PMID: 33573321 DOI: 10.3390/metabo11020081] [Reference Citation Analysis]
87 White JR, Phillips F, Monaghan T, Fateen W, Samuel S, Ghosh S, Moran GW. Review article: novel oral-targeted therapies in inflammatory bowel disease. Aliment Pharmacol Ther. 2018;47:1610-1622. [PMID: 29672874 DOI: 10.1111/apt.14669] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
88 Longo S, Chieppa M, Cossa LG, Spinelli CC, Greco M, Maffia M, Giudetti AM. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 2020;8:18. [PMID: 32784952 DOI: 10.3390/proteomes8030018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1720-1728. [PMID: 21530738 DOI: 10.1053/j.gastro.2011.01.054] [Cited by in Crossref: 293] [Cited by in F6Publishing: 291] [Article Influence: 26.6] [Reference Citation Analysis]
90 Li Q, Liang X, Xue X, Wang K, Wu L. Lipidomics Provides Novel Insights into Understanding the Bee Pollen Lipids Transepithelial Transport and Metabolism in Human Intestinal Cells. J Agric Food Chem. 2020;68:907-917. [PMID: 31842537 DOI: 10.1021/acs.jafc.9b06531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
91 Marsilio S, Chow B, Hill SL, Ackermann MR, Estep JS, Sarawichitr B, Pilla R, Lidbury JA, Steiner JM, Suchodolski JS. Untargeted metabolomic analysis in cats with naturally occurring inflammatory bowel disease and alimentary small cell lymphoma. Sci Rep 2021;11:9198. [PMID: 33911166 DOI: 10.1038/s41598-021-88707-5] [Reference Citation Analysis]
92 Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, Sauk JS, Wilson RG, Stevens BW, Scott JM, Pierce K, Deik AA, Bullock K, Imhann F, Porter JA, Zhernakova A, Fu J, Weersma RK, Wijmenga C, Clish CB, Vlamakis H, Huttenhower C, Xavier RJ. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4:293-305. [PMID: 30531976 DOI: 10.1038/s41564-018-0306-4] [Cited by in Crossref: 341] [Cited by in F6Publishing: 306] [Article Influence: 85.3] [Reference Citation Analysis]
93 Torrecillas S, Montero D, Domínguez D, Robaina L, Izquierdo M. Skin Mucus Fatty Acid Composition of Gilthead Sea Bream (Sparus Aurata): A Descriptive Study in Fish Fed Low and High Fish Meal Diets. Fishes 2019;4:15. [DOI: 10.3390/fishes4010015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
94 Shi L, Dai Y, Jia B, Han Y, Guo Y, Xie T, Liu J, Tan X, Ding P, Li J. The inhibitory effects of Qingchang Wenzhong granule on the interactive network of inflammation, oxidative stress, and apoptosis in rats with dextran sulfate sodium-induced colitis. J Cell Biochem. 2019;120:9979-9991. [PMID: 30548311 DOI: 10.1002/jcb.28280] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
95 Pride AC, Herrera CM, Guan Z, Giles DK, Trent MS. The outer surface lipoprotein VolA mediates utilization of exogenous lipids by Vibrio cholerae. mBio 2013;4:e00305-13. [PMID: 23674613 DOI: 10.1128/mBio.00305-13] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
96 Rohrhofer J, Zwirzitz B, Selberherr E, Untersmayr E. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis. Front Immunol 2021;12:635704. [PMID: 34054805 DOI: 10.3389/fimmu.2021.635704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Stremmel W, Staffer S, Gehrke S. The Detergent Effect of Mesalazine Interferes with Phosphatidylcholine Binding to Mucin 2. Inflamm Intest Dis 2019;3:107-15. [PMID: 30820432 DOI: 10.1159/000493347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
98 Ehehalt R, Braun A, Karner M, Füllekrug J, Stremmel W. Phosphatidylcholine as a constituent in the colonic mucosal barrier--physiological and clinical relevance. Biochim Biophys Acta 2010;1801:983-93. [PMID: 20595010 DOI: 10.1016/j.bbalip.2010.05.014] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
99 Rieder F, Karrasch T, Ben-horin S, Schirbel A, Ehehalt R, Wehkamp J, de Haar C, Velin D, Latella G, Scaldaferri F, Rogler G, Higgins P, Sans M. Results of the 2nd Scientific Workshop of the ECCO (III): Basic mechanisms of intestinal healing. Journal of Crohn's and Colitis 2012;6:373-85. [DOI: 10.1016/j.crohns.2011.11.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
100 Karner M, Kocjan A, Stein J, Schreiber S, von Boyen G, Uebel P, Schmidt C, Kupcinskas L, Dina I, Zuelch F, Keilhauer G, Stremmel W. First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses. Am J Gastroenterol. 2014;109:1041-1051. [PMID: 24796768 DOI: 10.1038/ajg.2014.104] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
101 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Reference Citation Analysis]
102 van Schaik FD, Gadaleta RM, Schaap FG, van Mil SW, Siersema PD, Oldenburg B, van Erpecum KJ. Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis. PLoS One 2012;7:e49706. [PMID: 23189156 DOI: 10.1371/journal.pone.0049706] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
103 Vesga P, Flury P, Vacheron J, Keel C, Croll D, Maurhofer M. Transcriptome plasticity underlying plant root colonization and insect invasion by Pseudomonas protegens. ISME J 2020;14:2766-82. [PMID: 32879461 DOI: 10.1038/s41396-020-0729-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
104 Kovács T, Varga G, Érces D, Tőkés T, Tiszlavicz L, Ghyczy M, Boros M, Kaszaki J. Dietary Phosphatidylcholine Supplementation Attenuates Inflammatory Mucosal Damage in a Rat Model of Experimental Colitis. Shock 2012;38:177-85. [DOI: 10.1097/shk.0b013e31825d1ed0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
105 Cai H, Wen Z, Xu X, Wang J, Li X, Meng K, Yang P. Serum Metabolomics Analysis for Biomarkers of Lactobacillus plantarum FRT4 in High-Fat Diet-Induced Obese Mice. Foods 2022;11:184. [PMID: 35053915 DOI: 10.3390/foods11020184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]